Anlon Healthcare schedules Q2 and H1 FY27 earnings call

Board & Shareholder Meetings View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹24.80

prior close

₹25.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 173sector+2.0%-3.8% vs sector

On the reaction day the stock moved 3.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

+0.6

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8pendingpending+2.0-3.8

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anlon Healthcare has scheduled an earnings conference call for Tuesday, November 3, 2026 at 5:00 PM IST to discuss unaudited results for the quarter ended September 30, 2026, covering Q2 and H1 FY27. Chairman and Managing Director Punit Kumar Rasadia will represent management.

Likely market impact

The call may provide updates on operating and financial performance, but no results or guidance were disclosed in this filing.